| Bioactivity | Lenvatinib N-Oxide (Lenvatinib impurity 10) is the impurity of Lenvatinib (HY-10981). Lenvatinib (E7080) is an orally active, multi-targeted tyrosine kinase inhibitor[1]. |
| CAS | 1788901-86-9 |
| Formula | C21H19ClN4O5 |
| Molar Mass | 442.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kudo M, et al. Lenvatinib versus Bay 43-9006 in first-line treatment of patients with unresectable hepatocellularcarcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018 Mar 24;391(10126):1163-1173. |
Lenvatinib N-oxide
CAS: 1788901-86-9 F: C21H19ClN4O5 W: 442.85
Lenvatinib N-Oxide (Lenvatinib impurity 10) is the impurity of Lenvatinib (HY-10981). Lenvatinib (E7080) is an orally ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.